LOS ANGELES CAPITAL MANAGEMENT LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1177206
LOS ANGELES, CA
Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$579,435
+$81,210 QoQ
Shares Held
4,727
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#204
of 341 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. PTGX ranks #51 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in PTGX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579,435 | 4,727 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $498,225 | 4,727 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $412,856 | 4,727 | Shares | Sole | 2026-02-11 | |
| 2024-12-31 | $1,210,727 | 31,366 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,010,070 | 22,446 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,068,155 | 30,827 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $891,825 | 30,827 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $209,901 | 9,154 | Shares | Sole | 2024-02-06 | |
| 2023-06-30 | $258,688 | 9,366 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,045,879 | 45,473 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $839,960 | 76,990 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $649,025 | 76,990 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $561,056 | 70,930 | Shares | Sole | 2022-08-05 | |
| 2021-03-31 | $1,227,323 | 47,387 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $967,821 | 48,007 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $913,121 | 46,707 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $824,845 | 46,707 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $205,566 | 29,117 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||